Advanced search
Start date
Betweenand


Tris[2-(1,3-thiazol-2-yl-kappa N)-1H-benzimidazole-kappa N-3]zinc(II) dinitrate ethanol hemisolvate monohydrate at 100 K

Full text
Author(s):
Oliveira, F. L. ; Huber, P. C. ; Almeida, W. P. ; Sabino, J. R. ; Aparicio, R.
Total Authors: 5
Document type: Journal article
Source: ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS; v. 69, p. 13-pg., 2013-02-01.
Abstract

The Zn-II center in the dicationic complex of the title compound, [Zn(C10H7N3S)(3)](NO3)(2)center dot 0.5C(2)H(5)OH center dot H2O, is in a distorted octahedral environment with imperfect noncrystallographic C-3 symmetry. Each 2-(1,3-thiazol-2-yl)-1H-benzimidazole ligand coordinates in a bidentate manner, with the Zn-N(imidazole) bond lengths approximately 0.14 angstrom shorter than the Zn-N(thiazole) bond lengths. Charge-assisted hydrogen bonds connect cations, anions and water molecules. A lattice void is occupied by an ethanol solvent molecule disordered about a crystallographic inversion center and pi-stacking is observed between one type of symmetry-related benzene rings. (AU)

FAPESP's process: 10/20861-2 - Development of candidate drugs for the treatment of Alzheimer's disease. I. investigation of metal chelators as inhibitors of the beta-amyloid aggregation; II. Development of tacrine-ibuprofen hybrids
Grantee:Wanda Pereira Almeida
Support Opportunities: Regular Research Grants
FAPESP's process: 09/51602-5 - Chemical biology: new natural and synthetic molecular targets against cancer, structural studies, biological evaluation and mode of action
Grantee:Ronaldo Aloise Pilli
Support Opportunities: Research Projects - Thematic Grants